Gluten Sensitivity among Egyptian Infants with Congenital Heart Disease

Inas R El-Alameey1, Hanaa H Ahmed2, Sawsan M Tawfik1

  • 1Child Health Department, National Research Centre, Giza, Egypt.

Insights

Infants with congenital heart disease (CHD) and gastrointestinal issues show higher antigliadin antibodies, indicating a link to malnutrition. Early gluten introduction may exacerbate these symptoms in vulnerable infants.

Area of Science:

  • Pediatric Gastroenterology
  • Cardiology
  • Immunology

Background:

  • Gastrointestinal symptoms are frequently observed in infants diagnosed with congenital heart disease (CHD).
  • Malnutrition is a significant concern in infants with CHD, often accompanied by digestive problems.

Purpose of the Study:

  • To assess age-dependent serum levels of antigliadin antibodies in malnourished Egyptian infants with CHD and gastrointestinal symptoms.
  • To investigate the relationship between antigliadin antibodies and malnutrition in infants with congenital heart disease.

Main Methods:

  • A case-control study involving 60 infants with CHD, divided into cyanotic and acyanotic groups (30 each).
  • Comparison with 30 age, sex, and social class-matched healthy infants.
  • Serum antigliadin antibodies were quantified using enzyme-linked immunosorbent assay (ELISA).

Main Results:

  • Infants with CHD exhibited significantly higher serum antigliadin antibody levels compared to controls (P < 0.000).
  • The mean age for introducing cereals and the onset of gastrointestinal symptoms was six months.
  • Factors such as age of onset of GI symptoms, diarrhea, abdominal pain, and distension were significantly associated with elevated antigliadin antibodies in malnourished CHD infants.

Conclusions:

  • Serum IgA, IgM, and IgG antigliadin antibodies are implicated in the pathogenesis of malnutrition in infants with CHD.
  • Delayed introduction of gluten-containing foods beyond six months is recommended for infants with CHD to mitigate malnutrition risks.
Abstract

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.8K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
967
Other Disorders of Digestive System01:30

Other Disorders of Digestive System

The gastrointestinal tract is susceptible to various disorders. If the lower esophageal sphincter is damaged, stomach acid can flow back into the esophagus, causing irritation and inflammation of the lining. This condition is called gastroesophageal reflux disease (known as heartburn) and may cause chest pain and difficulty swallowing. In the stomach, prolonged use of nonsteroidal anti-inflammatory drugs like aspirin, chronic alcohol consumption, bacterial infections such as Helicobacter...
1.6K